MedTrace Logo

Role of Glycation and Inflammation in Acute Ischemic Heart Disease

NCT05112731 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-02-16

No results posted yet for this study

Summary

This study requires the consecutive enrollment of 60 patients following the first event of acute myocardial infarction, evaluating B-Cell Activating Factor (BAFF) and methylglyoxal (MGO) levels in the acute setting (pre-reperfusion) and 3 months after reperfusion.

Conditions

Interventions

DIAGNOSTIC_TEST

BAFF and MGO

measurement of BAFF and MGO levels before reperfusion and after 3 months

Sponsors & Collaborators

  • Istituto Clinico Città Studi

    collaborator UNKNOWN

  • GEK Srl

    lead INDUSTRY

Principal Investigators

  • Michele Bianchi, MD · Istituto Clinico Città Studi

  • Altin Palloshi, MD · Istituto Clinico Città Studi

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05112731 on ClinicalTrials.gov